The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004

Breast cancer in the most common cancer among Malaysian women. There are many prognostic factors contributing to the disease and the outcome of the patients. Hence, a retrospective study was carried out aiming to observe the outcome of breast cancer patient in terms of overall survival with relat...

Full description

Saved in:
Bibliographic Details
Main Author: Mohamed, Moharzudi
Format: Thesis
Language:English
Published: 2010
Subjects:
Online Access:http://eprints.usm.my/56245/1/DR%20MOHARZUDI%20MOHAMED%20-%20e.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-usm-ep.56245
record_format uketd_dc
spelling my-usm-ep.562452023-02-14T07:58:38Z The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004 2010 Mohamed, Moharzudi R Medicine (General) RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Breast cancer in the most common cancer among Malaysian women. There are many prognostic factors contributing to the disease and the outcome of the patients. Hence, a retrospective study was carried out aiming to observe the outcome of breast cancer patient in terms of overall survival with relation to estrogen receptor (ER), progesterone receptor (PR) and c erbB-2 expression. In addition, patient's age, histological subtype, tumor grade, tumor size and lymph node involvement were also analyzed against overall survival, ER, PR and c erbB-2 expression. 115 cases of breast cancer diagnosed in three years, 2002 to 2004, were reviewed. It was found that ER and PR status were positive in 45.2% and 48.7% respectively while 39.1% showed c erbB-2 overexpression. There was significant association between ER status with tumour grade, tumour size, and PR status. Significant association was also found between PR status with tumour grade. There was significant association between c erbB-2 status with tumour grade and lymph nodes involvement. Univariate analysis showed shorter overall survival in patients with lymph node positive status, ER negativity, and c-erbB-2 oncoprotein overexpression. In multivariate prognostic analysis, c erbB-2 status was the strongest independent prognostic factor and ER status was the second most significant independent prognostic factor for overall survival. However, lymph node status was not a significant independent prognostic factor. From these finding, it was concluded that c erbB-2 and ER status was the strongest prognostic factors contributing to the outcome of breast cancer patients. 2010 Thesis http://eprints.usm.my/56245/ http://eprints.usm.my/56245/1/DR%20MOHARZUDI%20MOHAMED%20-%20e.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian sains perubatan
institution Universiti Sains Malaysia
collection USM Institutional Repository
language English
topic R Medicine (General)
R Medicine (General)
spellingShingle R Medicine (General)
R Medicine (General)
Mohamed, Moharzudi
The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
description Breast cancer in the most common cancer among Malaysian women. There are many prognostic factors contributing to the disease and the outcome of the patients. Hence, a retrospective study was carried out aiming to observe the outcome of breast cancer patient in terms of overall survival with relation to estrogen receptor (ER), progesterone receptor (PR) and c erbB-2 expression. In addition, patient's age, histological subtype, tumor grade, tumor size and lymph node involvement were also analyzed against overall survival, ER, PR and c erbB-2 expression. 115 cases of breast cancer diagnosed in three years, 2002 to 2004, were reviewed. It was found that ER and PR status were positive in 45.2% and 48.7% respectively while 39.1% showed c erbB-2 overexpression. There was significant association between ER status with tumour grade, tumour size, and PR status. Significant association was also found between PR status with tumour grade. There was significant association between c erbB-2 status with tumour grade and lymph nodes involvement. Univariate analysis showed shorter overall survival in patients with lymph node positive status, ER negativity, and c-erbB-2 oncoprotein overexpression. In multivariate prognostic analysis, c erbB-2 status was the strongest independent prognostic factor and ER status was the second most significant independent prognostic factor for overall survival. However, lymph node status was not a significant independent prognostic factor. From these finding, it was concluded that c erbB-2 and ER status was the strongest prognostic factors contributing to the outcome of breast cancer patients.
format Thesis
qualification_level Master's degree
author Mohamed, Moharzudi
author_facet Mohamed, Moharzudi
author_sort Mohamed, Moharzudi
title The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
title_short The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
title_full The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
title_fullStr The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
title_full_unstemmed The outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
title_sort outcome of breast cancer based on the expression of c-erbb2 , estrogen receptor and progesterone receptor: kelantan experience 2002-2004
granting_institution Universiti Sains Malaysia
granting_department Pusat Pengajian sains perubatan
publishDate 2010
url http://eprints.usm.my/56245/1/DR%20MOHARZUDI%20MOHAMED%20-%20e.pdf
_version_ 1776101156353736704